Soluble VCAM-1 Release Indicates Inflammatory Blood-Brain Barrier Pathology and Further Modulates Adhesion
Cellular adhesion molecules, like VCAM-1 and ICAM-1, and their counter-receptors are involved in the adhesion of lymphocytes to endothelial cells in areas of inflammation. They are also a prerequisite for the transmigration process of immune cells into the inflamed tissue, e.g., across the blood-brain barrier (BBB) during inflammatory central nervous system (CNS) diseases . Adhesion molecules can be induced by proinflammatory cytokines, like tumor necrosis factor-a (TNF-α), on various cell types, e.g., endothelial cells, macrophages, and lymphocytes .
KeywordsMultiple Sclerosis Blood Brain Barrier Peripheral Blood Mononuclear Cell Multiple Sclerosis Patient Cellular Adhesion Molecule
Unable to display preview. Download preview PDF.